Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Red Bank, New Jersey
- Most recent report
- 8-K, filed Sep 8, 2026
- Incorporated
- Delaware
- Filings on record
- 701 filings
- On EDGAR
- CIK 1583771
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 57
News 8 of 261
Prospectuses and Registrations 8 of 54
- S-8 Registration statement for an employee plan Aug 7, 2026
- 25-NSE Notice that a security was delisted Jul 22, 2025
- 424B4 Final prospectus for an offering Jan 23, 2025
- S-1/A Registration statement for an offering, amended Jan 14, 2025
- S-1 Registration statement for an offering Dec 26, 2024
- 424B3 Prospectus supplement for an offering Jul 15, 2024
- S-1 Registration statement for an offering Jul 11, 2024
- S-1 Registration statement for an offering Oct 31, 2023
Proxies 8 of 43
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- PRE 14A Preliminary proxy statement Apr 16, 2025
- DEF 14A Proxy statement for a shareholder vote Feb 7, 2025
- PRE 14A Preliminary proxy statement Jan 27, 2025
- DEFA14A Extra proxy material Dec 5, 2024
- DEFA14A Extra proxy material Dec 2, 2024
Ownership 8 of 190
- 4 Insider reported a trade Aug 21, 2026
- 4 Insider reported a trade Aug 21, 2026
- 4 Insider reported a trade Aug 21, 2026
- 4 Insider reported a trade Aug 21, 2026
- 4 Insider reported a trade Aug 21, 2026
- 4 Insider reported a trade Aug 21, 2026
- 4 Insider reported a trade Aug 21, 2026
- 3 Insider reported their initial holding Aug 21, 2026
Other 8 of 96
Everything here comes from Hepion Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.